Tag: GlaxoSmithKline
ViiV Healthcare secures Dovato EMA approval for HIV-1 treatment
Dovato EMA approval : The European Commission (EC) has approved ViiV Healthcare’s once-daily, single-pill, two-drug regimen Dovato (dolutegravir/lamivudine) for the treatment of human immunodeficiency virus ... Read More
GSK offloads rare disease gene therapy drugs to Orchard Therapeutics
Pharma acquisition news : British drug company GlaxoSmithKline (GSK) has agreed to transfer its rare disease gene therapy drugs to Orchard Therapeutics for an equity ... Read More
GSK to buy out Novartis’ stake in consumer healthcare JV for $13bn
Pharma acquisition news : GlaxoSmithKline (GSK) has agreed to buy out Swiss pharma company Novartis’ stake of 36.5% in their consumer healthcare joint venture (JV) ... Read More
GSK, Reckitt Benckiser pull out from $20bn race to acquire Pfizer’s consumer healthcare business
Pharma acquisition news : In a blow to Pfizer’s plans to offload its consumer healthcare business for about $20 billion, both Reckitt Benckiser and now ... Read More